NCT00785525View on ClinicalTrials.gov

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

PHASE3RecruitingINTERVENTIONAL
Enrollment

60,000

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
Healthy
Interventions
DRUG

Filgrastim

PBSC donors will receive 10 µg/kg of filgrastim subcutaneously each day of a five day mobilization schedule.

Trial Locations (4)

10016

RECRUITING

DKMS Americas, New York

20852

RECRUITING

C.W. Bill Young Marrow Donor Center, Rockville

33431

RECRUITING

Gift of Life Bone Marrow Foundation, Boca Raton

55401

RECRUITING

Be The Match, Minneapolis

All Listed Sponsors
collaborator

National Marrow Donor Program

OTHER

lead

Center for International Blood and Marrow Transplant Research

NETWORK